Megestrol
- Level
- Commodity
- Parent
- 51351500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351510This classification denotes a therapeutic progestin with the molecular formula C22H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EA6LD1M70M, chemically known as 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione but generally known as megestrol, which bears US NIH Compound Identifier 19090. European Medicines Agency schedules Megestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08712MIG. World Health Organization schedules megestrol in its Anatomical Therapeutic Chemical (ATC) Classification. MEGESTROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule megestrol under HS 29372300 and SITC 54153. As of Q4 2014, MEGESTROL remains the US FDA Preferred Term for this commodity. Megestrol bears US NLM identifiers UMLS ID C0025175 and NCI Concept Code C630. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)C(=C3)C)C)CC2)CC1)C)C(=O)C.
Same parent
Under 51351500 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.